A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin

Leisha Emens; Deborah Kay Armstrong; Barbara Biedrzycki; Nancy E. Davidson; Janice Davis Sproul; John H Fetting; Elizabeth Jaffee; Beth Onners; Steven Piantadosi; Richard T. Reilly; Vered Stearns; Irena Tartakovsky; Kala Visvanathan; Antonio Wolff

doi:10.1089/104303404322886165

A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin

Leisha Emens, Deborah Kay Armstrong, Barbara Biedrzycki, Nancy E. Davidson, Janice Davis Sproul, John H Fetting, Elizabeth Jaffee, Beth Onners, Steven Piantadosi, Richard T. Reilly, Vered Stearns, Irena Tartakovsky, Kala Visvanathan, Antonio Wolff

Research output: Contribution to journal › Review article › peer-review

32 Scopus citations

Original language	English (US)
Pages (from-to)	313-337
Number of pages	25
Journal	Human gene therapy
Volume	15
Issue number	3
DOIs	https://doi.org/10.1089/104303404322886165
State	Published - Mar 2004

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Genetics

Access to Document

10.1089/104303404322886165

Cite this

Emens, L., Armstrong, D. K., Biedrzycki, B., Davidson, N. E., Davis Sproul, J., Fetting, J. H., Jaffee, E., Onners, B., Piantadosi, S., Reilly, R. T., Stearns, V., Tartakovsky, I., Visvanathan, K., & Wolff, A. (2004). A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin. Human gene therapy, 15(3), 313-337. https://doi.org/10.1089/104303404322886165

A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin. / Emens, Leisha; Armstrong, Deborah Kay; Biedrzycki, Barbara et al.
In: Human gene therapy, Vol. 15, No. 3, 03.2004, p. 313-337.

Research output: Contribution to journal › Review article › peer-review

Emens, L, Armstrong, DK, Biedrzycki, B, Davidson, NE, Davis Sproul, J, Fetting, JH , Jaffee, E, Onners, B, Piantadosi, S, Reilly, RT, Stearns, V, Tartakovsky, I, Visvanathan, K & Wolff, A 2004, 'A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin', Human gene therapy, vol. 15, no. 3, pp. 313-337. https://doi.org/10.1089/104303404322886165

Emens L, Armstrong DK, Biedrzycki B, Davidson NE, Davis Sproul J, Fetting JH et al. A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin. Human gene therapy. 2004 Mar;15(3):313-337. doi: 10.1089/104303404322886165

@article{13fd218a71c44b74bbeca5e7a58a8068,

title = "A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin",

author = "Leisha Emens and Armstrong, {Deborah Kay} and Barbara Biedrzycki and Davidson, {Nancy E.} and {Davis Sproul}, Janice and Fetting, {John H} and Elizabeth Jaffee and Beth Onners and Steven Piantadosi and Reilly, {Richard T.} and Vered Stearns and Irena Tartakovsky and Kala Visvanathan and Antonio Wolff",

year = "2004",

month = mar,

doi = "10.1089/104303404322886165",

language = "English (US)",

volume = "15",

pages = "313--337",

journal = "Human gene therapy",

issn = "1043-0342",

publisher = "Mary Ann Liebert Inc.",

number = "3",

}

TY - JOUR

T1 - A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin

AU - Emens, Leisha

AU - Armstrong, Deborah Kay

AU - Biedrzycki, Barbara

AU - Davidson, Nancy E.

AU - Davis Sproul, Janice

AU - Fetting, John H

AU - Jaffee, Elizabeth

AU - Onners, Beth

AU - Piantadosi, Steven

AU - Reilly, Richard T.

AU - Stearns, Vered

AU - Tartakovsky, Irena

AU - Visvanathan, Kala

AU - Wolff, Antonio

PY - 2004/3

Y1 - 2004/3

UR - http://www.scopus.com/inward/record.url?scp=12144287913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12144287913&partnerID=8YFLogxK

U2 - 10.1089/104303404322886165

DO - 10.1089/104303404322886165

M3 - Review article

C2 - 15018740

AN - SCOPUS:12144287913

SN - 1043-0342

VL - 15

SP - 313

EP - 337

JO - Human gene therapy

JF - Human gene therapy

IS - 3

ER -

A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this